Humana closed at $417.42 on Nov 4, down 0.11%, 3.7% below its 52-week closing high. Volume of 1.9M shares was 1.17× its 20-day average (close to normal).
Split-adjusted performance: +3.3% over one month, +69.5% over six months, +49.1% over one year.
In the quarter ended Jun 30, 2026, revenue was $40.87B, up 26.2% from a year earlier, with a net margin of 1.7%.
Short interest was 3.7M shares at the Oct 15 settlement, up 31.4% from the prior report (3.1% of float, 2.0 days to cover).